Edition:
United States

Integra LifeSciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

54.07USD
23 Feb 2018
Change (% chg)

$1.14 (+2.15%)
Prev Close
$52.93
Open
$53.00
Day's High
$54.16
Day's Low
$53.00
Volume
227,693
Avg. Vol
189,911
52-wk High
$56.39
52-wk Low
$40.51

Chart for

About

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $4,243.27
Shares Outstanding(Mil.): 78.48
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 33.67 16.59
EPS (TTM): -- -- --
ROI: -- 14.21 35.07
ROE: -- 16.88 17.79

BRIEF-Integra Lifesciences Announces Preliminary Q4 Earnings Per Share View $0.55, Revenue View $351.0

* - ‍ORGANIC REVENUE GROWTH IN Q4 IS EXPECTED TO BE ABOUT 5.5%, ABOVE COMPANY'S IMPLIED GUIDANCE OF ABOUT 4%​

Jan 08 2018

BRIEF-Integra Lifesciences Holdings Corp ‍Reaffirms 2017 Financial Guidance As Provided On Oct 26, 2017​

* - ‍REAFFIRMING 2017 FINANCIAL GUIDANCE AS PROVIDED ON OCTOBER 26, 2017​

Dec 11 2017

BRIEF-Capital Research Global Investors Reports 11.1 Pct Passive Stake In Integra Lifesciences As Of Nov 30

* CAPITAL RESEARCH GLOBAL INVESTORS REPORTS 11.1 PERCENT PASSIVE STAKE IN INTEGRA LIFESCIENCES HOLDINGS CORP AS OF NOVEMBER 30 - SEC FILING Source text: (http://bit.ly/2jb88l1) Further company coverage:

Dec 08 2017

BRIEF-Integra Lifesciences Q3 adjusted earnings per share $0.45

* Integra Lifesciences reports third quarter 2017 financial results

Oct 26 2017

BRIEF-JNJ announces completion of Codman Neurosurgery divestiture to Integra Lifesciences

* Johnson & Johnson announces completion of Codman Neurosurgery divestiture to Integra Lifesciences Holding Corporation Source text for Eikon: Further company coverage:

Oct 02 2017

FTC approves Integra purchase of J&J’s Codman business

WASHINGTON Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

U.S. FTC approves Integra purchase of J&J’s Codman business

WASHINGTON Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

UPDATE 1-U.S. FTC approves Integra purchase of J&J’s Codman business

WASHINGTON, Sept 27 Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

FTC allows Integra to buy J&J’s Codman neuro business, with conditions

WASHINGTON, Sept 27 Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

BRIEF-Integra lifesciences reports preliminary assessment of damage to Puerto Rico facility

* Integra Lifesciences provides preliminary assessment of minor damage to its manufacturing facility in Añasco, Puerto Rico

Sep 26 2017

Earnings vs. Estimates